Search - tctmd.com

Displaying 961 - 980 of 1251

Sort: Relevancy | Date

News Daily News

Climbing Everest? Cardiac Arrhythmias Join Other Fabled Risks

Michael O'Riordan

April 04, 2024

News Conference News ACC 2024

Faster CAC Progression After Menopause May Warrant Intensified Therapy

L.A. McKeown

April 04, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2024

Shelley Wood

April 03, 2024

News Daily News

Class I Recall for 330,000 Radial Artery Catheterization Kits: FDA

Yael L. Maxwell

April 03, 2024

News Conference News ACC 2024

Lack of Sleep Ups Hypertension Risk, Especially for Women

Yael L. Maxwell

April 03, 2024

News Industry News

Concept Medical receives US FDA approval for MagicTouch AVF indication, their fifth US clinical study approval for the MagicTouch portfolio

April 03, 2024

News Conference News ACC 2024

Heavy Drinking May Contribute to CHD Risk in Young Women

L.A. McKeown

April 02, 2024

News Daily News

FDA Approves TriClip TEER Device for Tricuspid Repair

L.A. McKeown

April 02, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Conference News ACC 2024

ADHD Meds Linked to Cardiomyopathy in Young Adults

Todd Neale

April 01, 2024

News Daily News

Antihypertensives Linked to Lower Long-term Dementia Risk

Caitlin E. Cox

April 01, 2024

News Features

The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns

Todd Neale

March 29, 2024

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

News Daily News

ACC Chest Pain Pathway Performs Well Overall, Less So for Those With CAD

Yael L. Maxwell

March 28, 2024

News Conference News ACC 2024

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

Michael O'Riordan

March 27, 2024

News Daily News

DCB in STEMI Match DES Through 5 Years: REVELATION

Caitlin E. Cox

March 27, 2024

News Daily News

Biologic Winrevair Wins FDA Approval for Treatment of PAH

L.A. McKeown

March 27, 2024

News Conference News ACC 2024

Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT

Todd Neale

March 27, 2024

News Daily News

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Michael O'Riordan

March 26, 2024

Advertisement

Climbing Everest? Cardiac Arrhythmias Join Other Fabled Risks

Faster CAC Progression After Menopause May Warrant Intensified Therapy

TCTMD’s Top 10 Most Popular Stories for March 2024

Class I Recall for 330,000 Radial Artery Catheterization Kits: FDA

Lack of Sleep Ups Hypertension Risk, Especially for Women

Concept Medical receives US FDA approval for MagicTouch AVF indication, their fifth US clinical study approval for the MagicTouch portfolio

Heavy Drinking May Contribute to CHD Risk in Young Women

FDA Approves TriClip TEER Device for Tricuspid Repair

April 2024 Dispatch for the CV Team

What’s Going to Be Hot at ACC 2024

ADHD Meds Linked to Cardiomyopathy in Young Adults

Antihypertensives Linked to Lower Long-term Dementia Risk

The Promise of Pulsed-Field Ablation: Cautious Optimism Amid Some Unknowns

Evoque and Patisiran: A Tale of Two Regulatory Journeys

ACC Chest Pain Pathway Performs Well Overall, Less So for Those With CAD

Most HFrEF Patients Eligible for Quadruple Therapy, but Few Get It

DCB in STEMI Match DES Through 5 Years: REVELATION

Biologic Winrevair Wins FDA Approval for Treatment of PAH

Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content